Related Experiment Video
Updated: Jul 15, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
[Pathogenic role of insufficiency of polycomb repressive complex in primary myelofibrosis]
1Department of Hematology, Tokyo Metropolitan Tama Medical Center.
Abstract:
Primary myelofibrosis (PMF) is characterized by the clonal expansion of megakaryocytes and myeloid cells from stem cells with abnormal cytokine expression, resulting in bone marrow fibrosis, angiogenesis, and osteosclerosis. The use of next-generation sequencing revealed that both genetic and epigenetic changes are important in the pathogenesis of PMF. Several epigenetic regulator genes, including TET2, the polycomb-related gene ASXL1, and the polycomb-group gene EZH2, have been found to be targeted by somatic gene mutations in PMF patients. Among these, loss of Ezh2 has been demonstrated to disrupt the function of the polycomb repressive complex 2, promoting the development of JAK2V617F-induced myelofibrosis in mice. In this analysis, we highlight the role of PRC dysfunction in the pathogenesis of PMF.
Insights
Primary myelofibrosis involves abnormal cell growth and bone marrow fibrosis. Polycomb repressive complex (PRC) dysfunction, particularly involving EZH2, is a key factor in its development.
Area of Science:
- Hematology
- Molecular Biology
- Epigenetics
Context:
- Primary myelofibrosis (PMF) is a bone marrow cancer characterized by fibrosis, angiogenesis, and osteosclerosis.
- Genetic and epigenetic alterations are crucial in PMF pathogenesis.
- Somatic mutations in epigenetic regulators like TET2, ASXL1, and EZH2 are observed in PMF patients.
Purpose:
- To highlight the role of Polycomb Repressive Complex (PRC) dysfunction in the pathogenesis of Primary myelofibrosis.
- To elucidate the impact of EZH2 mutations on PMF development.
Summary:
- PMF involves clonal expansion of myeloid cells and megakaryocytes with aberrant cytokine production.
- Loss of EZH2 function disrupts PRC2, promoting JAK2V617F-induced myelofibrosis in murine models.
- Epigenetic dysregulation, specifically PRC dysfunction, is central to PMF pathogenesis.
Impact:
- Understanding PRC dysfunction offers insights into PMF mechanisms.
- Identifies potential therapeutic targets for PMF by focusing on epigenetic regulators.
- Contributes to the knowledge of myeloproliferative neoplasms and their underlying molecular drivers.
Related Concept Videos
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
The Intrinsic Apoptotic Pathway
Master Transcription Regulators

